Please try another search
China Jo-Jo Drugstores, Inc. reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was USD 78.57 million compared to USD 72.72 million a year ago. Net loss was USD 0.924247 million compared to USD 0.594781 million a year ago. Basic loss per share from continuing operations was USD 0.77 compared to USD 2.62 a year ago. Diluted loss per share from continuing operations was USD 0.77 compared to USD 2.62 a year ago.
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Revenue | 38.04 | 38.04 | 36.36 | |
Gross Profit | 8.68 | 8.68 | 8.46 | |
Operating Income | -9.84 | -9.84 | -0.622 | |
Net Income | -0.462 | -10.27 | -10.27 | -0.297 |
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Assets | 90.97 | 90.97 | 101.77 | |
Total Liabilities | 74.3 | 74.3 | 79.83 | |
Total Equity | 16.67 | 16.67 | 21.93 |
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -2.17 | -2.17 | 0.529 | |
Cash From Investing Activities | -0.116 | -0.116 | -0.042 | |
Cash From Financing Activities | 2.67 | 2.67 | -1.49 | |
Net Change in Cash | 1.06 | 1.06 | -2.94 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review